Moderna (MRNA) Reports Interim Data From Phase 1 Study of mRNA-2752 Triplet Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 188.70 -13.93 (6.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.63 | 52 Week High | $0.52 | |||
| Open | $196.69 | 52 Week Low | $0.08 | |||
| Day High | $200.41 | P/E | N/A | |||
| Day Low | $186.60 | EPS | $-3.80 | |||
| Volume | 2,263,939 | |||||
